KR840004091A - 티아졸 유도체의 제조방법 - Google Patents

티아졸 유도체의 제조방법 Download PDF

Info

Publication number
KR840004091A
KR840004091A KR1019830001082A KR830001082A KR840004091A KR 840004091 A KR840004091 A KR 840004091A KR 1019830001082 A KR1019830001082 A KR 1019830001082A KR 830001082 A KR830001082 A KR 830001082A KR 840004091 A KR840004091 A KR 840004091A
Authority
KR
South Korea
Prior art keywords
formula
alkyl
general formula
thiazole derivative
compound
Prior art date
Application number
KR1019830001082A
Other languages
English (en)
Inventor
파울 피오치 리차드
Original Assignee
아더 알.웨일
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아더 알.웨일, 일라이 릴리 앤드 캄파니 filed Critical 아더 알.웨일
Publication of KR840004091A publication Critical patent/KR840004091A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194Radicals derived from thio- or thiono carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Earth Drilling (AREA)
  • Inert Electrodes (AREA)
  • Treating Waste Gases (AREA)

Abstract

내용 없음

Description

티아졸 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 일반식(Ⅴ)의 아민을 일반식(여기에서 L1는 이탈그룹이다.)의 화합물 또는 일반식 RR8R9C-N-=C=A의 시약과 반응시키거나, 일반식(Ⅴ′)의 화합물을 일반식 H2NCR8R9R의 아민과 반응시키거나, 일반식(Ⅴ″)의 화합물을 일반식 H2NCR8R9R(여기에서 R은 C2-4알케닐이다.)의 아민과 반응 시키거나, 또는 일반식 (Ⅴ"')의 화합물의 염을 일반식 HS(CH2)n-NH-CA-NH-CR8R9R의 티올과 반응시킴을 특징으로 하여 일반식(XX)의 티아졸 유도체 및 그의 약제학적으로 허용되는 염을 제조하는 방법.
    상기식에서
    R1및 R2는 각각 독립적으로 H 또는 (C1-C4)-알킬이고,
    R1및 R2중 하나는 젠질 또는 벤조일 일 수 있으며,
    R1및 R2는 이들이 부착된 질소와 함께 1 또는 2개의 헤테로원자를 함유한 5 내지 7원 포화헤테로사이 클릭 환을 형성할 수 있고, 단 Z가 CH2인 경우 R1및 R2중의 단지 하나가 H일 수 있으며,
    R3는 H 또는 (C1-C3)알킬이고,
    Z는 O, S 또는 CH2이며,
    n은 Z가 S 또는 0인 경우 2 또는 3이고, Z가 CH2인 경우는 1,2 또는 3이며;
    m는 1,2 또는 3이고;
    R5는 H 또는 CH3이며 ;
    A는 N-CN, N-NO2, CH-NO2, S, O, NH, N-(C1-C4)-알킬, N-SO2-아릴, N-SO2-(C1-C4)-알킬, N-CO-NH2, N-CO-(C1-C4)-알킬, N-CO2-(C1-C4)-알킬, CH-SO2-아릴 또는 CH-SO2-(C1-C4)-알킬(여기에서 아릴은 페닐, 할로페닐, (C1-C4)-알킬페닐 또는 (C1-C4)-알킬옥시페닐이다)이고;
    R은 (C2-C4) 알케닐 또는 (C2-C4)-알키닐이며;
    R8및 R9는 각각 독립적으로 H, CH3또는 C2H5이며, 단 CR8R9R 그룹에 있어서 탄소원자의 총수는 7보다 작아야 하고;
    L2는 이탈그룹이며;
    L3는 바람직한 이탈그룹이다.
  2. 제1항에 있어서, Z가 S이고 n이 2인 일반식(XX)의 티아졸 유도체 또는 그의 약제학적으로 허용되는 염의 제조방법.
  3. 제1항 또는 2항에 있어서, R이 에티닐이며 R9및 R9이 둘다 수소인 일반식(XX)의 티아졸 유도청 또는 그의 약제학적으로 허용되는 염의 제조방법.
  4. 제1항에 있어서, N-(2-프로피닐)-N'-2-(2-디메틸아미노메틸-4-티아졸릴메틸티오) 에틸 2-니트로-1,1-에렌디아민의 제조방법.
  5. 제1항에 있어서, N-(2-프로피닐)-N'-2-(2-디메틸아미노메틸-4-티아졸릴메틸티오) 에틸-N"-시아노구아니딘의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830001082A 1982-03-19 1983-03-17 티아졸 유도체의 제조방법 KR840004091A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/360,034 US4474794A (en) 1982-03-19 1982-03-19 N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
US360,034 1982-03-19

Publications (1)

Publication Number Publication Date
KR840004091A true KR840004091A (ko) 1984-10-06

Family

ID=23416322

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001082A KR840004091A (ko) 1982-03-19 1983-03-17 티아졸 유도체의 제조방법

Country Status (22)

Country Link
US (1) US4474794A (ko)
EP (1) EP0091220B1 (ko)
JP (1) JPS58170773A (ko)
KR (1) KR840004091A (ko)
AT (1) ATE27156T1 (ko)
AU (1) AU1254583A (ko)
CA (1) CA1190547A (ko)
CS (1) CS236788B2 (ko)
DD (1) DD207376A5 (ko)
DE (1) DE3371514D1 (ko)
DK (1) DK91083A (ko)
ES (1) ES520791A0 (ko)
FI (1) FI830879L (ko)
GB (1) GB2116973B (ko)
GR (1) GR77882B (ko)
IL (1) IL68152A0 (ko)
NZ (1) NZ203605A (ko)
PH (1) PH18504A (ko)
PL (1) PL241066A1 (ko)
PT (1) PT76397B (ko)
RO (1) RO85385B (ko)
ZA (1) ZA831882B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
ATE86619T1 (de) * 1987-04-06 1993-03-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
NL9000132A (nl) * 1990-01-19 1991-08-16 Cedona Pharm Bv Nieuwe thiazoolderivaten.
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
PL241066A1 (en) 1985-01-02
EP0091220A2 (en) 1983-10-12
GB2116973B (en) 1985-08-29
IL68152A0 (en) 1983-06-15
AU1254583A (en) 1983-09-22
GB2116973A (en) 1983-10-05
CA1190547A (en) 1985-07-16
JPS58170773A (ja) 1983-10-07
FI830879L (fi) 1983-09-20
DK91083D0 (da) 1983-02-25
ATE27156T1 (de) 1987-05-15
PT76397A (en) 1983-04-01
PT76397B (en) 1986-02-04
FI830879A0 (fi) 1983-03-16
ZA831882B (en) 1984-11-28
EP0091220B1 (en) 1987-05-13
ES8405386A1 (es) 1984-06-01
PH18504A (en) 1985-08-02
DD207376A5 (de) 1984-02-29
EP0091220A3 (en) 1984-05-23
DK91083A (da) 1983-09-20
CS236788B2 (en) 1985-05-15
GR77882B (ko) 1984-09-25
RO85385A (ro) 1984-11-25
GB8307201D0 (en) 1983-04-20
NZ203605A (en) 1985-10-11
DE3371514D1 (en) 1987-06-19
US4474794A (en) 1984-10-02
RO85385B (ro) 1984-11-30
ES520791A0 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
KR830007602A (ko) N-티아졸릴메틸 티오알킬-n'-알킬아미딘의 제조방법
KR870011129A (ko) 디스타마이신 a 동족체 및 이의 제조방법
KR870006016A (ko) N-벤조일 우레아 화합물, 이를 함유하는 항종양 조성물 및 그의 제조 방법
KR890000485A (ko) 캠프토데신 유도체 및 그의 아미노기에 있어서의 산 부가염 및 4급 암모늄염 및 그의 제조방법
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
KR920019777A (ko) 치환된 3-(피리딘일아미노)-인돌 및 벤조[b]티오펜, 이의 제조방법 및 약제로서의 이의 용도
KR830006198A (ko) 시클로헥산 유도체의 제조방법
KR910016695A (ko) 4-(아미노메틸) 피페리딘 유도체, 그의 제조방법 및 치료에의 이용
KR840004091A (ko) 티아졸 유도체의 제조방법
KR850006936A (ko) 티오페닐우레아의 제조방법
KR840005118A (ko) 헤테로사이클릭 아민의 제조방법
KR930700435A (ko) 디티오카르밤산의 염류, 그 제조방법 및 그 디티오카르밤산의 염류를 사용하는 이소티오시아네이트류의 제조방법
KR910000133A (ko) 아민
KR960029312A (ko) N-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
KR870008848A (ko) 페닐우레아의 제조방법
KR880013929A (ko) 신규 5-메톡시 알킬 암노늄 테트라히드로푸란 및 테트라히드로티오펜
KR880012595A (ko) 유기화합물 및 약제로서 이의 용도
ES423164A1 (es) Un metodo para la preparacion de derivados de carbalcoxi- tioureidobenceno.
KR910006292A (ko) 방향족 산의 n-아자비시클로 [3.3.0] 옥탄 아미드
KR840006012A (ko) 포스페이트 유도체의 제조방법
PT78410A (fr) Procede de preparation de polymethylene imines disubstituees
KR840001580A (ko) 6'-(2-아미노-2-〔4-아실욕시페닐〕아세트아미도페니실라노 일옥시메틸 페니실라네이트 1,1-디옥사이드 화합물의 제조방법
KR850005435A (ko) 3-알콕시-2-(n-피롤리디노)-n-피리미디닐-또는 n-피라지닐 프로필아민의 제조방법
GB1391802A (en) Derivatives or homologues of cysteamine
KR890003690A (ko) 우레아 유도체

Legal Events

Date Code Title Description
SUBM Surrender of laid-open application requested